All-Party Parliamentary Group on Personalised Medicine

As a global leader in both scientific and technological innovation, the UK is poised to lead a healthcare revolution. The All-Party Parliamentary Group on Personalised Medicine provides a platform to help prepare health systems, policy and populations for the impact of 21st century biomedical science and technology – and crucially, how to put patients at the centre of their care.

The All-Party Parliamentary Group on Personalised Medicine - chaired by Helen Whately MP and co-chaired by Lord Norman Warner – gives members of both Houses of Parliament the opportunity to drive the agenda for investment and innovation in the life sciences to create a more efficient and effective NHS for the benefit of patients and the wider UK population.

The APPG seeks to:

  1. Examine the potential of new and emerging scientific research and technologies to shape and improve future health and care

  2. Ensure that the fruits of investment and innovation in the life sciences are adopted in the NHS for the benefit of patients and the wider public 

  3. Work towards the creation of a sustainable health service for the 21st century and beyond by realising the transformative power of personalised medicine driven by bioscience and technology

Over 100 parliamentarians and stakeholders celebrated the official launch of the APPG on 15 March 2016. To find out more about this parliamentary group's activities, visit their website.

The PHG Foundation provides the secretariat for this parliamentary group, working in partnership with the British Medical Journal (BMJ), the Wellcome Trust Sanger Institute and the Northern Health Science Alliance Ltd. (NHSA) to provide all the support necessary to achieve this group’s ambitious mandate.

To discuss becoming a member of this transformative parliamentary group, or to find out more about supporting the work of the group, contact appg@phgfoundation.org or +44 (0)1223 761906.